Insiders Ardelyx, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
7.77 ^USD	-3.60%		-10.89%	+25.32%

05-09	Ardelyx Insider Sold Shares Worth $2,522,217, According to a Recent SEC Filing	MT
05-09	Ardelyx Insider Sold Shares Worth $1,831,503, According to a Recent SEC Filing	MT

Ardelyx Insider Sold Shares Worth $2,522,217, According to a Recent SEC Filing	05-09	MT
Ardelyx Insider Sold Shares Worth $1,831,503, According to a Recent SEC Filing	05-09	MT
Ardelyx Insider Sold Shares Worth $333,574, According to a Recent SEC Filing	05-07	MT
Ardelyx, Inc. Announces the Appointment of Mike Kelliher as Executive Vice President, Corporate Development and Strategy	03-25	CI
Ardelyx Insider Sold Shares Worth $664,978, According to a Recent SEC Filing	03-22	MT
Ardelyx Insider Sold Shares Worth $253,925, According to a Recent SEC Filing	12-13	MT
Ardelyx Insider Sold Shares Worth $105,476, According to a Recent SEC Filing	12-08	MT
Ardelyx Announces Departure of Geoffrey Block as Board Member	11-13	CI
Insider Buy: Ardelyx	17/11/22	MT
Fulcrum Therapeutics Appoints Santiago Arroyo as Chief Medical Officer, Jeff Jacobs as Chief Scientific Officer	08/11/22	MT
Insider Sell: Ardelyx	07/10/22	MT
Ardelyx, Inc. Announces Executive Changes	14/03/22	CI
Ardelyx, Inc. Announces Board Changes	15/03/21	CI
Insider Trends: Insider Purchase Eases Back 90-Day Trend of Sales at Ardelyx	10/12/20	MT
Ardelyx, Inc. Announces Executive Changes	10/06/20	CI
Ardelyx, Inc. Appoints Justin Renz as Chief Financial Officer	08/06/20	CI
Ardelyx, Inc. Announces Appointment of Susan Rodriguez as First Chief Commercial Officer	18/05/20	CI
Ardelyx, Inc Announces Management and Board Changes	16/03/20	CI
Ardelyx, Inc. Announces Resignation of Mark Kaufmann as Chief Financial Officer	26/11/19	CI
Ardelyx, Inc. Announces Board Changes	18/03/19	CI

No results for this search